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Abstract
In recent years, a social trend toward delaying childbearing
has been observed in women of reproductive age. A novel techno-
medical innovation was commercialized for non-medical reasons
to healthy, ostensibly fertile women, who wished to postpone
motherhood for various reasons such as educational or career
demands, or because they had not yet found a partner. As a conse-
quence, these women may be affected by age-related infertility
when they decide to conceive, and fertility preservation tech-
niques can be obtained through the so-called social egg freezing.
This paper examines, from an ethical point of view, the impact of
social egg freezing under some aspects that can involve policy
making and resources allocation in public health. Due to the
increasing demand for this procedure, some debated issues regard
if it is reasonable to include social egg freezing in Public
Healthcare System and consequently how to manage the storage
of cryopreserved oocytes also from individual donors, how to sup-
port these egg banks and how to face, in the future, with the pos-
sibility that egg freezing will play a role in enabling childbearing
for gays, lesbians, and unmarried persons. Social freezing may be
advertised to harmonise gender differences, but we wonder if it is
the proper solution to the problem or if it could also create further
challenges. An ethical argumentation on these topics should
address some questions that will be discussed.
Introduction
Fertility preservation is an emerging field that provides the
opportunity to maintain reproductive health to all those patients
who either have to receive medical treatments or want to preserve
their gametes to postpone childbearing (age-related fertility
preservation). The majority of patients who can benefit from fer-
tility preservation techniques are cancer patients: in fact, chemo-
and radiotherapy given in some cancer therapies have detrimental
consequences on male and female gonads that may lead to infer-
tility.1-3 Other disorders, such as autoimmune diseases and
myelodysplastic syndromes, require medical treatment that can
also impair reproductive cells and tissues. In medical situations,
fertility preservation is also indicated in other circumstances
where germ cell degeneration is observed, in particular women
affected by premature ovarian failure (POF) based on idiopathic or
genetic origin as in Turner syndrome mosaicism, X trisomy, and
X-fragile syndrome, may also benefit from fertility preservation.4
Social egg freezing means to preserve and store a woman’s
oocytes for non-medical purposes.
The fact that female fecundity decreases with increasing age
was recognised in several demographic and epidemiological stud-
ies that consistently demonstrated a decline in fertility beginning
as early as the middle of the third decade.5,6 The incontrovertible
effect of ageing on female reproductive function is most notable in
the decline in ovarian function. Ovarian ageing causes a progres-
sive loss of the finite pool of primordial follicles, ultimately result-
ing in menopause, and apart from this quantitative decline, an age-
dependent decline in the quality of oocytes mainly as a result of
increased chromosomal aneuploidy.
Today, a social trend toward delaying childbearing has been
observed in women of reproductive age. This delay is due to dif-
ferent factors related to lifestyle such as development of a profes-
sional career or absence of the right partner. As a consequence,
these women may be affected by age-related infertility when they
decide to conceive, and fertility preservation techniques is pro-
posed as a solution for these women.
Recent studies in literature indicate significantly more success
with the technique of oocyte vitrification, that means to transform
a substance into glass to render it stable through very rapid cooling
to about -100°C, where molecular activity stopped.7 This tech-
nique is undoubtedly useful in clinical applications, that are repre-
sented first of all by patients who may have fertility impairment as
consequence of diseases or therapies; furthermore, elective cryop-
reservation of oocytes may be a possible clinical application as a
form of prevention in age-related decline in women fertility, if we
consider this decline as an age-related women’s disease, rather
than a manifestation of physiological changes.8
On social and non-medical
The advent of successful oocyte freezing techniques has
Significance for public health
One of the purposes of medicine in health policies is the recognition of the
different health needs of men and women because of their differences, that
we can define gender equity, which should be guaranteed. Social egg freez-
ing means to preserve and store a woman’s oocytes for non-medical purpos-
es. This paper discusses how social freezing may be advertised to harmonise
these incompatibilities and, if oocyte cryopreservation is an accepted proce-
dure to counter infertility and if fertility treatment is covered by public
healthcare, the consequence may be that it may also be covered by public
national healthcare system or we have to admit that there is a distinction
between assisted reproductive technologies for medical reasons and assisted
reproductive technologies with oocytes previously stored for non-medical
reasons.
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opened the doors to a new medical and societal phenomenon of
oocyte freezing to avoid age-related subfertitlity.9
Social freezing means egg storing of a healthy, fertile woman,
in order to have a pregnancy later in her life, i.e. at the age of 45 to
50,10 it should ideally be performed on women around 25 years of
age in order to increase their chances of a future pregnancy, but, in
reality, it is mostly performed after the age of 35. While the option
for cancer patients to freeze oocytes, in the face of treatments that
may render them infertile, is generally considered in a positive
light, offering the same option to healthy women, for the previous-
ly indicated reasons, is met with new ethical challenges.
Until recently egg freezing was offered only for medical rea-
sons, to women facing cancer treatments, or other fertility-impair-
ing conditions, who had no other options for fertility preservation,
this medical innovation is being widely promoted by private fertil-
ity centres and the lay press throughout the world, to healthy,
ostensibly fertile women, who wished to postpone motherhood for
various reasons such as educational or career demands, or because
they had not yet found a partner. Furthermore, in 2014, Facebook
and Apple made headlines by offering to give female employees
$20,000 of egg-freezing benefits as a nudge policy to encourage
people to make healthier choices.11,12 Public reaction to the mean-
ing of this opportunity was mixed: some viewed the development
positively as a forward-thinking practice that would give greater
flexibility and peace of mind to young female employees to avoid
the pressure because of their declining ovarian reserve, while oth-
ers were sceptical that women would be the true beneficiaries,
arguing that it would create implicit pressure to partake in egg
freezing and delay motherhood in order to demonstrate seriousness
and dedication to the workplace.13,14
The association of the term social to a certain treatment com-
monly indicates the absence of a medical indication, for the fact
that it refers to medical treatments performed purely based on the
desire of a person. Social egg freezing is by no means a social
activity as there are no other people involved apart from the
woman herself. This treatment is not part of the social notion of
solidarity in the altruistic sense either, given that the oocytes will
be used by the woman herself, and considering that egg donors
undertake these risks to save someone else’s life like organ dona-
tion, but to enable other women to raise a child. The act would only
be social if the woman determines that she does not need her
frozen oocytes and decides to donate them to another woman to
use them. Unfortunately, at the moment, the average age of the
women who perform oocyte banking is too old to be considered
suitable for oocyte donation: it should ideally be performed on
women around 25 years of age (in order to increase their chances
of a future pregnancy) but, it is mostly performed after the age of
35 and these oocytes are too old for being considered for
donation.15,16Although societal changes have led to an overall
postponement of motherhood, it is the prevention of age-related
infertility that motivates women to store their gametes. Who is in
favour of oocyte freezing supports the concept that, also if it is a
deliberate choice, it is impossible to judge to what extent a
women’s timing to become a mother could be a deliberate choice,
or an inherent need, to proceed to methods to optimize future
reproductive chances. The indication for oocyte cryopreservation
makes this procedure a preventive medical treatment rather than a
non-medical treatment. Therefore, the term social freezing sounds
judgemental to those women who undertake preventive action by
implicitly inferring that these women chose to postpone mother-
hood. Moreover, considering that fertility preservation in oncolog-
ical patients is never considered non-medical, in the same way,
women that take preventive actions to protect themselves against
iatrogenic gonadal damage, by treatments such as chemotherapy,
are therefore also protecting themselves against ovarian ageing. In
other words, it is not because treatments are described as non-med-
ical that they are to be considered social, and treatments are not
necessarily non-medical because they have no immediate curative
nature. The focus of oocyte cryopreservation lies on the preventive
aspect of subfertility with a possibly curative function in the future.
Some may argue that conditions relating to ageing do not need to
be prevented, as they are natural.17
At this point the question that could arise is if we can define
maternal age as a disease and only in this view social freezing
could be a solution for age related fertility decline considered as a
medical problem which should be prevented by this relatively new
technology.18 In other words, social egg freezing seems to be a pre-
ventive measure regarding the women fertility. 
Social egg freezing and assisted reproductive tech-
nology 
The procedure of oocyte cryopreservation finds its completion
in the application of Assisted Reproductive Technology (ART),
given that the collection and storage of oocytes can be justified
from the perspective of their use at a later date by an appeal to
ART.
In fact, elective oocyte freezing consists of two separate steps
that are clearly distinct in time: first, ovarian stimulation, oocyte
retrieval, cryopreservation and storage that we identify in the
oocyte banking; and second, even several years later, thawing and
fertilization of the cryopreserved oocytes. At the time of the first
step, women who request social freezing are healthy persons who
ask for a procedure that results in stored oocytes that may or may
not be used, depending on the further course of their lives. From a
medical point of view, we have to consider the balance between the
risks of the procedures (ovarian hyper stimulation, oocyte pick up
and pregnancy) and the benefits, for the mother and the child. In
bioethical terms the balance between the respect of the woman
autonomy (including the reproductive autonomy) and the benefi-
cence both for the mother and the child.
Every medical intervention has its inherent risks: here there
exists for the mother many health risks due to the In Vitro
Fertilization by Intracytoplasmic Sperm Injection (IVF-ICSI)
treatment, especially in woman over 45 years of age: with increas-
ing age, pre-pregnancy chronic medical conditions and obstetrical
risks and adverse birth outcomes rise; even though maternal mor-
tality rates are very low in Europe, they are increasing with
increasing age. Other concerns are the possibility to create high
and potentially false hopes and introducing medical processes to
primary fertile women. Furthermore, in an ethical perspective, we
should also consider the risks for the future child: due to advanced
maternal age and pregnancy complications, neonatal complica-
tions are also increased, comprising prematurity and lower mean
birth weights among infants of women older than 50 years old
compared with younger women.
In case of assisted reproductive techniques, the pregnancy rate
per embryo transfer for women receiving IVF treatment using their
own fresh eggs drops between the ages of 35 and 45 from 38.2%
to 2.2%. If a woman freezes her eggs before her fertility starts to
decline, IVF using her own frozen eggs will be more likely to work
into her late 30s and 40s. For women freezing their eggs in their
mid-20s to mid-30s, there is a clinical pregnancy rate per thawed
oocyte of between 4.5% and 12%. Although not identical, pregnan-
cy rates for IVF using frozen oocytes are now broadly comparable
with pregnancy rates using fresh oocytes, so that a woman who
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froze her eggs at the age of 35 could benefit from an IVF success
rate closer to 38% than 2% well into her 40s. The optimum time to
freeze one’s eggs, from a clinical point of view, would be during a
woman’s teens or 20s.16
Should countries with publicly funded ART extend
coverage to social freezing?
If oocyte cryopreservation is an accepted procedure to counter
infertility and if fertility treatment is covered by public healthcare,
should the logical consequence then be that social freezing is also
covered by public national healthcare system (or mandated insur-
ance coverage) or it should be admitted that there is a relevant dis-
tinction between ART and ART with oocytes previously stored for
non-medical reasons?
The term “elective freezing”, that is also found in literature as
a synonymous for social freezing, puts the focus on the idea that
oocyte cryopreservation by healthy women resembles other
instances of elective medical interventions - such as cosmetic
surgery - that generally have no therapeutic benefit unless psycho-
logical. This sparks the sentiment that there is no reason why soci-
ety should finance such desires of women who want to have it all.
A likely objection to full coverage is that this could be a sub-
optimal allocation of scarce funds: healthcare budgets are strained
and several countries are already struggling to accommodate the
requests for ART. At the same time, the added costs might not be
overwhelming: ovarian stimulation and oocyte retrieval are
uncomfortable procedures that women will only undertake if they
are convinced that they will actually benefit from the procedure.19
Today, Israel is one of the first countries in which egg freezing
for non-medical reasons has been regulated and authorised for
public support, with the justification of “permitting egg freezing to
prevent both disease- and age-related fertility decline … so women
are then free to exercise their reproductive autonomy and decide
for themselves whether or not the technology is beneficial to
them”. This choice is based on conviction that social egg freezing
is grounded in liberal ideology promoting the individual autonomy
exercised through informed consent, supporting that a relational
approach to autonomy may be a more suitable model for consider-
ing women’s choices about egg freezing, also for non-medical pur-
poses.20
Social and ethical consideration on women’s reproductive
autonomy regarding the choice of social freezing should take into
account the possible pressures to which women are already con-
fronted when trying to realise both their professional aspirations
and motherhood. It has to be considered that pregnancy, delivery
and raising children does not ever really fit into a woman’s career
plan, independently of mother age. There is no “ideal time” and it
is always complicated to organise child care whatever the age of
the mother, e.g. before and after school, in the case of childhood
illness, during the weeks and months of school holidays and so on.
In addition, reports in the lay press on more or less famous women
giving birth to a child at around the age of 50 are presenting a dis-
torted picture of reality. Furthermore, studies around the world
have shown that young people are not aware of the natural limits
of human fertility,21,22 consequently, young women should be
informed by doctors of the decreasing chances of pregnancy with
increasing maternal age, as well as the increasing risks of miscar-
riage and obstetrical/neonatal complications due to the women’s
fertility decline in order to allow women to plan their reproductive
choices more realistically, thus reducing the chance of involuntary
childlessness.23 On the other hand, the information should be accu-
rate in order to avoid the risk that women would consider the pos-
sibility to access to social egg freezing as a commercialized repro-
ductive insurance policy that encourages them to freeze their eggs
in case they need to use them in the future.14
Social egg freezing and egg banking
As an alternative to embryo cryopreservation, that may not be
an option for all couples, because of personal religious or moral
objections, or restrictive legislation in certain countries, oocyte
donation has become an integral part of ART. In recent years, the
demand for oocyte donation has increased, as it has become a treat-
ment option for large numbers of women experiencing age-related
infertility. Oocyte cryopreservation has led to the development of
donor oocyte banks, which allow recipients to review a list of
donors, and minimize waiting times.8 As well as cryopreserved
oocytes from individual donors, surplus oocytes from infertile cou-
ples may be cryopreserved and subsequently donated.
We expect women to be less reluctant to donate oocytes to
other patients when spare oocytes are already in storage - a number
of oocytes during the course of an ART treatment can remain
unused due to a myriad of reasons: women may have completed
their family through natural conception or in vitro fertilization with
other oocytes, may have passed away or break up with their partner
or may have abandoned their desire to have children - than when a
woman has to undergo the stimulation and retrieval procedures
specifically for the purpose of donation or when donation implies
a decrease in the woman’s own chance of conceiving (such as in
oocyte sharing). We have to take into account that potential donors
need to overcome a double threshold: the first with regard to the
physically demanding procedures of ovarian stimulation and
oocyte retrieval; secondly, with regard to the psychological burden
of becoming the genetic parent of a child that one does not know.
However, the psychological threshold remains largely intact:
many, if not most, women find the idea of having a genetic child
grow up in an unknown family emotionally troubling, and there-
fore, even if the physical burden is lifted, it is unlikely that large
numbers of women with spare oocytes will be donating them for
reproductive purposes. In fact, at present, it seems that women are
keen to come forward as donors unless when directed (or cross-)
donation to a friend or family member is concerned, or when
donors receive a personal benefit, either cash or in kind (in oocyte-
sharing schemes).15 Nevertheless, there are a number of practical
benefits from the use of the donor egg bank: it simplifies the logis-
tics of ART cycles as there is no need for menstrual cycle synchro-
nization between donor and recipient; it allows for the testing of
donors for infectious diseases during quarantine; and it potentially
reduces cost through the efficient allocation of oocytes from a pool
of donors to many recipient such as recipients can make their own
choice from a large donor pool without waiting long for an appro-
priate match. Also, donors can programme their donation cycle to
easily fit their schedule and not be dependent on the recipient. Egg
banking also provides the possibility to quarantine oocytes for 6
months or longer to retest donors for safer donation, as is the cri-
teria established for semen banks. Additionally, egg banking pro-
vides the possibility of distributing oocytes among two or more
recipients, without facing any difficulties of endometrial synchro-
nization, which can also make the treatment more economical and
so more affordable. The storage of oocytes for donation shows a
positive impact on the management of an oocyte donation pro-
gramme, becoming easier and much more efficient at achieving
excellent clinical results, in fact as high as obtained with fresh
donor oocytes.8
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Future perspectives in technology
Finally, social egg freezing and egg banking can play a role in
fertility treatment enabling childbearing for gays, lesbians, and
unmarried persons. For example, a gay male couple could procure
a frozen donor egg and the services of a surrogate mother in order
to complete assisted reproduction procedures. A lesbian couple
might freeze their eggs while searching for donor sperm. As soci-
ety moves closer to accepting a universal human interest in repro-
ducing that is not confined to a heterosexual norm, it becomes
more difficult to justify the denial of access to assisted reproduc-
tive technologies on the basis of sexual orientation and/or marital
status. 
In a 2013 statement by its ethics committee, the American
Society for Reproductive Medicine (ASRM) called for programs
providing fertility services to “treat all requests for assisted repro-
duction equally without regard to marital/partner status or sexual
orientation.” They supported their recommendation with research
that suggests children are not harmed in their development by
being raised by same-sex parents. They also noted that claims of
physician autonomy or religious freedom are not legitimate bases
for discrimination on the basis of sexual orientation.24
To attempt to delineate the non-medical reasons for egg freez-
ing is already to begin an ethical analysis of what counts as a valid
reason for egg freezing. Discussing how egg freezing is paid for
similarly complicates our common understandings of health and
illness, necessity and choice. The deeper ethical questions raised
by social or nonmedical egg freezing do not yield to easy answers.
Does non-medical egg freezing promote sex equality or undermine
it? Does it enhance human health and well-being, or does it encour-
age a harmful artificiality? Answering these questions depends
largely on one’s prior normative frameworks, including how one
understands the nature and origin of sexual inequality and the pur-
pose and limits of medical technology. The objective in the field of
biomedicine and health planning in the context of both local and
global scale is the recognition of the different health needs of men
and women because of their differences, that we can define gender
equity, which should be guaranteed in public health policies.25
Conclusions
Cryopreservation of oocytes for later use as a form to prevent
age-related infertility is now seen as a viable technology that can
extend the window opportunity of pregnancy for those women
who defer motherhood for social reasons. 
We can conclude that, while a possible argument in favour of
social freezing could be to avoid discrimination between men and
women, we wonder if equality between men and women should be
achieved by erasing biological differences between them, or if
social freezing is the embodiment of the trend in society to accept
less and less the finiteness and unavailability of the human life.
In the same vein, must equality in the job market go hand in
hand with further medicalisation of reproduction? Will egg freez-
ing ease the pressure of finding a partner, or might it strengthen the
illusion that no compromises should be made, and women can wait
forever to find “prince charming”? Consequently, individual fertil-
ity assessment and counselling on egg freezing for fertility preser-
vation for age related fertility decline, should be offered to women
of reproductive age? 
One of the purposes of medicine in health policies is the recog-
nition of the different health needs of men and women because of
their differences, that we can define gender equity, which should
be guaranteed. 
Whatever strategy is put in place, starting from a condition of
equality in gender diversity, an achievable goal in medicine is to
ensure that both men and women are able to maximize their health
potential with respect to their biological diversity. In this context
strategies to achieve a state of gender equity should take into
account their different health needs.
Social freezing may be advertised to harmonise these incom-
patibilities, but we wonder if it is the proper solution to the prob-
lem or if it could also create further challenges.
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